~~<i id='7E1ECAC2FE'><strike id='7E1ECAC2FE'><tt id='7E1ECAC2FE'><pre id='7E1ECAC2FE'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：focus 2025-10-01 15:27:31 Page View：9

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump Jan. 6 attorney John Lauro is ex
Next article： FDA approval of Sarepta Duchenne genetic therapy gives me hope

explore

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

Russian and Belarusian players banned from a women's tennis tournament in Prague

FILE-ArynaSabalenkaofBelarusreactsassheplaysTunisia'sOnsJabeurinawomen'ssinglessemifinalmatchondayel

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Poland's lawmakers approve a divisive law on Russian influence

FILE-Poland'slawmakersvoteinparliament,inWarsaw,Poland,onMay26,2023.Poland'slawmakershavevotedtoappr